Preventive Care & DiagnosticsNutritional Neurology

Vitamin B12 Deficiency and Peripheral Neuropathy: Symptoms, Methylmalonic Acid (MMA) Testing, and Injection vs. Sublingual Protocols

A detailed physician reviewed guide on how to diagnose, screen and treat vitamin B12 deficiency. Including neurological symptoms such as subacute combined degeneration of the spinal cord, intrinsic factor, serum B12 assay ranges, Homocysteine and MMA, and Oral vs injectable Cyanocobalamin and Methylcobalamin.

Published: 2026-10-18Reviewed: October 2026Updated: 2026-10-31 10 min read 1685 Views
Listen to this guide Audio Edition

Hands-free audio narration

Educational Health Notice

This educational guide is researched in accordance with our Editorial Policy and public health guidelines. It is not personal medical advice. For clinical questions, read our Medical Disclaimer or consult a qualified healthcare provider.

Vitamin B12 lab blood test tubes, diagnostic report, and neurological nerve assessment

Quick Summary & Key Findings

Vitamin B12 (Cobalamin) is an essential water soluble micronutrient required for DNA synthesis, erythropoesis and myelin sheath maintenance. Vitamin B12 deficiency will cause a range of neurological symptoms including symmetrical paraesthesia (tingling, burning and numbing sensations in the toes and fingers), confusion, fatigue and a megaloblastic macrocytic anaemia. Serum tests for vitamin B12 levels are often falsely normal within the grey area (200-400pg/mL). Additional tests for Methylmalonic Acid and total plasma homocysteine should be performed. If these are elevated (>0.28µmol/L and >15µmol/L respectively), then deficiency can be confirmed. Treatment can be commenced early with high dose sublingual methylcobalmin (1000-2000 mcg per day) or Hydroxocobalamin. This stops further damage to the nerves and improves neurological function.

There are few more frustrating and avoidable situations within neurology and primary care than seeing a patient presenting with bilateral worsening numbness of their feet, gait instability in the dark, and atypical brain fogginess only to be told that their blood results were normal and their B12 was 245pg/mL. The reference range for vitamin B12 in serum from a commercial lab is often set at 180-200pg/mL as the lower limit. However strong neurochemical evidence shows that up to 30% of patients whose serum B12 falls into the 200-400pg/mL range will have severe functional cellular cobalamin deficiency.

Vitamin B12 (cobalamin) is an essential coenzyme for two key reactions in the body: Methionine synthase (conversion of homocysteine to methionine for DNA methylation) and Methylmalonyl-CoA mutase (conversion of methylmalonyl-CoA to Succinyl-CoA for myelin and citric acid cycle energy). A reduction in B12 causes rapid accumulation of MMA and Homocysteine. This causes damage to the endothelial cells of the vasculature and loss of the myelin sheaths in the posterior and lateral columns of the spinal cord – subacute combined degeneration.

The Physiology of Cobalamin: From Gastric Intrinsic Factor to Myelin Integrity

Vitamin B12 absorption is a complex, multi-organ physiological process vulnerable to disruption at several distinct gastrointestinal checkpoints:
Gastric Acid Cleavage and Haptocorrin Binding: B12 in food is bound to animal protein. Once in the stomach, hydrochloric acid and pepsin cause cleavage of the cobalamin from the protein in food. The free cobalamins immediately bind to the R-binder in saliva to protect them against destruction by gastric acid.
Pancreatic Proteolysis and Intrinsic Factor (IF). In the alkaline environment of the duodenum, haptocorrin is broken down by pancreatic proteases. This releases cobalamin so it can combine with Intrinsic Factor (a glycoprotein produced by gastric parietal cells).
Receptor-Mediated Ileal Endocytosis: The B12-IF complex is absorbed unchanged in the jejunum up until the last 100cm of the terminal ileum. Here cubam receptors allow the calcium dependent active transport of the complex into the epithelial cells. At this stage, if receptors have become saturated, only 1.5-2.0mcg will be absorbed per meal.
Passive Mucosal Diffusion: Oral administration of megadose pharmacological doses of B12 (1000-2000mcg) leads to absorption of 1-2% (10-40 mcg) of B12 by passive non-saturable transcellular diffusion throughout the intestine, without any requirement for an intrinsic factor and also without needing to bypass damaged ileum mucosa.

Neurological, Hematological, and Neuropsychiatric Symptom Checklist

Deficiency symptoms develop insidiously over months to years as hepatic stores (2 to 5 mg) slowly deplete:
Bilateral Sensory Paresthesias: Symmetric paresthesias, dysesthesias (burning sensations) or tingling, which start at the distal end of the toes and slowly ascend the leg in a stocking-glove pattern.
Sensory Ataxia/Impaired Proprioception: Stumbling when walking in the dark or when closing eyes in the shower (positive Romberg’s) due to demyelination of posterior spinal columns. n.
Loss of vibratory sensation: Patient is unable to feel the vibration of a 128Hz tuning fork placed over the first metatarsophalangeal joint and lateral malleolus.
★ Best pick Version 2 Neuropsychiatric changes (Megaloblastic Madness): Poor memory, poor executive function, extreme lack of motivation, treatment resistant depression, paranoia and unstable mood.

Etiology of Deficiency: Metformin, PPIs, Pernicious Anemia, and Diet

Identifying the root cause of B12 deficiency is critical to determining whether oral supplementation or lifelong parenteral injections are required:
Strict Vegetarian and Vegan Diets. Plants, fruits, vegetables and grains contain no bioavailable cobalamin. In the absence of supplementation, unfortified plant based diets will inevitably lead to depletion of hepatic B12 stores within 2-5 years.
Metformin-Induced Malabsorption: Metformin, the first line treatment for Type 2 Diabetes, inhibits cubam receptor calcium dependent endocytosis within the distal ileum. Between 10% and 30% of patients who take metformin long term will suffer from progressive B12 deficiency.
Proton Pump Inhibitors (PPIs) and H2 Blockers: Long term treatment with omeprazole/pantoprazole/famotidine will reduce gastric acid secretion. This will prevent any acid-peptic breakdown of dietary protein bound B12.
Autoimmune Pernicious Anemia. Autoantibodies against gastric parietal cells (anti-parietal cell antibodies, APCA) or intrinsic factor (anti-IF antibodies, highly specificity) cause chronic autoimmune atrophic gastritis and achlorhydria.

Transcobalamin Transport, Subacute Combined Degeneration & MMA Diagnostic Cutoffs

Vitamin B12 (cobalamin) is a water soluble cofactor required for 2 important enzymatic reactions within the human body. Firstly, it acts as a cofactor for methionine synthase converting homocysteine to methionine. This reaction requires methylcobalamin and 5-methyltetrahydrofolate. Secondly it acts as a cofactor for methylmalonyl-CoA mutase converting methylmalonyl-CoA to succinyl-CoA. This reaction requires 5’-deoxyadenosylcobalamin. Failure of reaction 1 will result in the trapping of folate in its unusable form preventing the synthesis of DNA purines and thymidine in the haematopoeitic precursor cells of the bone marrow causing megaloblastic macrocytic anaemia. Failure of reaction 2 will result in the accumulation of methylmalonic acid (MMA) in the cells. This will lead to abnormal branched fatty acids being incorporated into myelin sheaths of neurons causing Subacute Combined Degeneration (SCD) of the spinal cord.
Serum B12 thresholds: Normal (>350pg/ml) / Borderline/Equivocal (200-350pg/ml) requiring mandatory reflex metabolite results. / Overt deficiency (<200pg/ml) often associated with neurological or haematological features. (In pmol/L, >258pmol/L normal / 200-350pmol/L requiring reflex testing / <148pmol/L often associated with neurological or haematological features.)
Reflex Methylmalonic Acid (MMA) confirmation Serum MMA is the gold standard test for diagnosis (>0.40umol/L in the absence of renal failure). If MMA and total homocysteine levels are both raised (>15umol/L), then this confirms true tissue deficiency of intracellular cobalamin despite a borderline normal total B12 in serum.
Subacute Combined Degeneration (SCD) Neuropathy Demyelination of the posterior (dorsal) column and lateral column of the spinal cord. Symmetrical paraesthesia in lower limbs (pins and needles). Sensory ataxia (positive romberg test due to loss of proprioception). Reduced vibratory sensation (128Hz tuning fork). Spastic paraparesis with hyperreflexia. Babinski sign.
Pernicious Anemia Autoantibody Biomarkers: Gastric parietal cell autoimmune destruction leads to complete loss of gastric IF production. This can be confirmed by measuring serum Anti-Intrinsic Factor Antibodies (anti-IF, very specific >95%) and Anti-Parietal Cell Antibodies (anti-PCA, very sensitive ~90%).

High-Dose Oral Passive Diffusion vs. Intramuscular Injections & Drug Interactions

Clinical trials have definitively proven that high-dose oral cobalamin repletion matches the efficacy of intramuscular injections through passive paracellular intestinal absorption.
Passive Paracellular Diffusion: Physiological levels of B12 from the diet require active receptor endocytosis (via binding with Intrinsic Factor) in the terminal ileum. However, 1.0-1.2% of high dose free crystalline cobalamin can be absorbed by a passive diffusion mechanism via the intestinal enterocytes. This occurs by mass action, without any requirement for intrinsic factor or intact ileum. Maximum absorption is 1.5-2.0mcg per meal.
High Dose Oral Cyanocobalamin Protocol: Randomized controlled trials such as the Minneapolis VA trial and Cochrane reviews have demonstrated that high dose oral cyanocobalamin (1000-2000mcg per day) is equally effective as intramuscular injections at correcting serum B12 levels, lowering raised MMA and providing neurological improvement.
Intramuscular (IM) Repletion for Severe SCD Patients presenting with acute progressive sensory ataxia or severe neurologic dysfunction: Cyanocobalamin/Hydroxocobalamin: 1,000 mcg IM daily x 7 days. Then weekly x 4 weeks. Then monthly to maintain immediate saturation of CNS tissues.
Drug-induced malabsorption triage (Metformin, PPIs). Long-term use of proton pomp inhibitors omeprazole will cause inhibition of gastric acid necessary for the digestion of cobalamin from dietary proteins. Metformin causes impaired calcium dependent membrane absorption in the ileum. Long term patients should have yearly B12 monitoring.

Clinical Neurological Localization: Posterior Column Deficits & The Folate Trap

Deficiency of vitamin B12 leads to a specific pattern of neurological damage known as Subacute Combined Degeneration (SCD). The demyelination occurs patchily in the mid-thoracic region in the posterior (dorsal) and lateral funiculi of the spinal cord and progresses rostrally and caudally. This causes damage to large, heavily myelinated axons which transmit proprioceptive and vibration sensations. Sensory nerve conduction velocity in the peripheral nerves may still be normal in the early stages when the lesion is purely within the spinal cord. Therefore detailed sensory examination is essential to make the diagnosis early.
Motor examination: Loss of vibration sense to a 128Hz tuning fork at the hallux interphalangeal joint and ankles is the first and most sensitive neurological feature. This is followed by loss of joint position sense, and a positive Romberg’s test (loss of balance or falling over when standing with eyes shut).
Mixed upper and lower motor neuron signs: Demyelination of the lateral corticospinal tracts results in spasticity, weakness and extensor plantar responses (positive Babinski sign) of the lower limbs. However, there is reduced or absent ankle jerk reflexes caused by co-existing large fibre peripheral neuropathy.
The Dangerous 'Folate Trap' Hazard: Administration of high doses of folic acid ( > 1000mcg/day) to an individual with undiagnosed vitamin B12 deficiency will result in "bypassing" the methionine synthase deficiency and thymidine synthesis will occur. Macrocytic megloblastic anaemia will be fully reversed, but subacute combined spinal cord degeneration will be allowed to progress to permanent paraplegia.
Reversible Neuropsychiatric Syndromes ('Megaloblastic Madness’). Cobalamin deficiency can lead to impaired central monoamine neurotransmitter and SAMe synthesis. This can result in progressive cognitive decline, acute confusion, paranoid psychosis, and severe depressive symptoms, all of which will fully improve with prompt cobalamin repletion.

Frequently Asked Questions

R
Clinical Reviewer License Verified

Dr. Randhir Sud, MBBS, MD, DM, MAMS

Chairman, Institute of Digestive & Hepatobiliary Sciences, Medanta – The Medicity • MBBS, MD, DM (Gastroenterology)
Medical Review Board

Dr. Randhir Sud is the Chairman of the Institute of Digestive and Hepatobiliary Sciences at Medanta – The Medicity, Gurugram. Recipient of the Padma Shri award, he is a pioneer in therapeutic gastrointestinal endoscopy, pancreatic-biliary disorders, and digestive health with over 35 years of clinical practice.

License ID: DMC-09180
Chairman, Institute of Digestive and Hepatobiliary Sciences, Medanta – The Medicity, Gurugram, Delhi NCR
Medically evaluated on October 2026View Dr. Profile, Verified Credentials & Articles

References & Clinical Resources

  1. Devalia V, Hamilton MS, Molloy AM, on behalf of the British Committee for Standards in Haematology. Guidelines for the diagnosis and treatment of cobalamin and folate disorders (2014-2024). [Access Resource Link] — British Journal of Haematology
  2. Langan RC, Goodbred AJ. Vitamin B12 Deficiency: Recognition and Management (2017-2024). [Access Resource Link] — American Family Physician (AAFP)
  3. Wang H, Li L, Qin LL, et al.. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency (2018). [Access Resource Link] — Cochrane Database of Systematic Reviews
  4. Aroda VR, Edelstein SL, Goldberg RB, et al.. Metformin-Associated Vitamin B12 Deficiency: Current Evidence and Practical Recommendations (2016-2024). [Access Resource Link] — The Journal of Clinical Endocrinology & Metabolism (JCEM)
Article Tools & Sharing:
Educational Resources
Patient Community Doctor Reviewed

Reader Reviews & Clinical Q&A

Real experiences, reader questions, and verified physician guidance.

5.0 out of 5 (0 reviews)

Leave a Review or Ask a Medical Question

5 / 5 Stars
* Reviews are reviewed by our clinical editorial team in accordance with our medical policies.